Replies to post #1211 on Conatus Pharmaceuticals Inc. (CNAT)

[Inoviorulez]

Me too I'm gonna keep adding until the phase 2b trial start is announced. If the stock continues to stay below $5 I will continue to accumulate shares. Because once Novartis takes the option to license Emricasan I don't see the stock staying in single digits for very long.